FDA’s Social Media Consumer Outreach Up
The pilot involved several CDER employees working together with OEA employees to respond to drug related inquiries posted on FDA’s Facebook page.
In 2014, The FDA’s Office of External Affairs (OEA) and Center for Drug Evaluation and Research (CDER) began a 90-day pilot program to improve consumer engagement by enhancing its social media responses, specifically to drug related inquiries more quickly and proactively. The pilot involved several CDER employees working together with OEA employees to respond to drug related inquiries posted on FDA’s Facebook page. The pilot was successful and as a result has become a permanent program.
Other highlights from the social media update are the dashboards offered-OEA Dashboard within the OC Administrative Offices Dashboard. Also noted in the dashboards is the delay of an implementation for an FDA-wide social media policy, targeted now for end of May 2016.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs. 2.4 mg, Placebo
January 17th 2025Semaglutide 7.2 mg significantly outperformed semaglutide 2.4 mg and placebo with a 20.7% average reduction in weight and a comparable safety and tolerability profile, further establishing its efficacy in obesity treatment.
